Remove tag adam-standard
article thumbnail

Q&A: A decade on, what’s next for CAR-T therapies?

Pharmaceutical Technology

But access to these treatments continues to remain limited due to high price tags and variable availability across regions. Adam Zamecnik: We observed the ten-year anniversary of the first patient being successfully treated with a CAR-T therapy in May 2022. This interview has been edited for clarity and length.

FDA 59